Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs).

Bioorg Med Chem

Cancer Research UK Centre for Cancer Therapeutics, The Institute of Cancer Research, Cancer Research UK Laboratories, Cotswold Road, Sutton, Surrey, SM2 5NG, UK.

Published: January 2009

High-throughput screening led to the identification of isothiazolones 1 and 2 as inhibitors of histone acetyltransferase (HAT) with IC50s of 3 microM and 5 microM, respectively. Analogues of these hit compounds with variations of the N-phenyl group, and with variety of substituents at C-4, C-5 of the thiazolone ring, were prepared and assayed for inhibition of the HAT enzyme PCAF. Potency is modestly favoured when the N-aryl group is electron deficient (4-pyridyl derivative 10 has IC(50)=1.5 microM); alkyl substitution at C-4 has little effect, whilst similar substitution at C-5 causes a significant drop in potency. The ring-fused compound 38 has activity (IC(50)=6.1 microM) to encourage further exploration of this bicyclic structure. The foregoing SAR is consistent with an inhibitory mechanism involving cleavage of the S-N bond of the isothiazolone ring by a catalytically important thiol residue.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2008.11.079DOI Listing

Publication Analysis

Top Keywords

inhibitors histone
8
synthesis isothiazol-3-one
4
isothiazol-3-one derivatives
4
derivatives inhibitors
4
histone acetyltransferases
4
acetyltransferases hats
4
hats high-throughput
4
high-throughput screening
4
screening led
4
led identification
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!